medigraphic.com
ISSN 2221-2434 (Electronic)

2014, Number 3

<< Back Next >>

Finlay 2014; 4 (3)

Transcranial ultrasound in the diagnosis of Parkinson’s disease

Martínez GA, Herrera PCA, Barba RR

Language: Spanish
References: 26
Page: 204-209
PDF size: 93.43 Kb.


ABSTRACT

Parkinson’s disease is the second most common neurodegenerative disorder and, since it is associated with aging, the probability of developing this disease increases with age. The diagnosis of idiopathic Parkinson’s disease is based on clinical criteria; however, its differentiation from other forms of Parkinsonism can be difficult, especially in early stages of the disease. Transcranial ultrasound has become a tool for the diagnosis of this disorder, being very useful for its early diagnosis. Ultrasonographic findings characteristic of this disease include increased echogenicity of the substantia nigra in the midbrain measured through the temporal bone window. This paper discusses the usefulness of transcranial ultrasound for early diagnosis of patients with Parkinson's disease.


REFERENCES

  1. Garbayo E, Aymerich MS, Ansorena E, Lanciego JL, Blanco MJ. Terapias neuroprotectoras y neurorestauradoras en el tratamiento de la enfermedad de Parkinson. An Sist Sanit Navar. 2006 ; 29 (3): 325-35.

  2. Bouwmans A, Vlaar A, Srulijes K, Weber U. Transcranial Sonography for the Discrimination of Idiopathic Parkinson’s Disease from the Atypical Parkinsonian Syndromes. International Review of Neurobiology. 2010 ; 90 (1): 121-146.

  3. Ministerio de Salud Pública. Anuario Estadístico de Salud 2013 [Internet]. La Habana: Dirección Nacional de Estadísticas; 2014. [ cited 15 Jul 2014 ] Available from: http://files.sld.cu/dne/files/2014/05/anuario-2013- esp-e.pdf.

  4. Morales H, Cervantes A, Rodríguez M. Diagnóstico premotor de la enfermedad de Parkinson. Gaceta médica de México. 2011 ; 147 (1): 22-32.

  5. Walter U. Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: no. J Neural Transm. 2011 ; 118 (4): 607-12.

  6. Vlaar A, de Nijs T, van Kroonenburgh M, Mess W, Winogrodzka A, Tromp S, et al. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans. BMC Neurol. 2008 ; 8 (1): 42.

  7. Miranda M. Ecografía Transcraneal como apoyo diagnóstico en la Enfermedad de Parkinson. Rev Chil Neuro-Psiquiat. 2007 ; 45 (1): 76-7.

  8. Miranda M, Linderman R. Avances en el diagnóstico de la Enfermedad de Parkinson: ecografía transcraneal. Rev Med Clin Condes. 2006 ; 17 (3): 116-9.

  9. Hernández J, Rubiera M, Lorenzo C, Castell J, Molina CA, Rodríguez FM. Utilidad de la sonografía del parénquima cerebral en la enfermedad de Parkinson: Estudio comparativo con I-FP-CIT SPECT. Med Clin (Barc). 2008 ; 131 (8): 285-9.

  10. Školoudík D, Walter U. Method and validity of transcranial sonography in movement disorders. Int Rev Neurobiol. 2010 ; 90 (1): 7-34.

  11. Olivares J. Utilidad diagnóstica y pronóstica de la ultrasonografía transcraneal en el parkinsonismo relacionado con el consumo de fármacos: estudio prospectivo [Internet]. Almería: Universidad de Granada; 2012. [ cited 22 Mar 2014 ] Available from: http://digibug.ugr.es/handle/10481/24017#.VCfw _FLTyf0.

  12. Miwa H. Transcranial sonography of the substantia nigra in patients with Parkinson´s disease. Rinsho Shinkeigaku. 2013 ; 53 (11): 981-2.

  13. Walter U. Transcranial sonography of the cerebral parenchyma:update on clinically relevant applications. Perspectives in Medicine. 2012 ; 1 (1-12): 334-43.

  14. Vlaar A, Bouwmans A, Mess W, Tromp S, Weber W. Transcranial duplex in the differential diagnosis of parkinsonian syndromes: a systematic review. J Neurol. 2009 ; 256 (4): 530-8.

  15. Mehnert S, Reuter I, Schepp K, Maaser P, Stolz E, Kaps M. Transcranial sonography for diagnosis of Parkinson´s disease. BMC Neurology. 2010 ; 10 (1): 9.

  16. Kwon D, Seo W, Yoon H, Park M, Koh S, Park K. Transcranial brain sonography in Parkinson´s disease with restless legs syndrome. Movement Disorders. 2010 ; 25 (10): 1373-8.

  17. Pedroso JL, Bor E, Felicio AC, Braga P, Dutra L, Aquinoa CC, et al. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. A preliminary observation. Journal of the Neurological Sciences. 2012 ; 319 (1-2): 59-62.

  18. Walter U, Skoloudik D, Berg D. Transcranial sonography findings related to non-motor features of Parkinson´s disease. J Neurol Sci. 2010 ; 289 (1-2): 123-7.

  19. Walter U, Behnke S, Eyding J, Niehause L, Postert T, Berg G. Transcranial brain parenchyma sonography in movement disorders: state of the art. Ultrasound in Medicine & Biology. 2007 ; 33 (1): 15-25.

  20. Godau J, Berg D. Role of Transcranial Ultrasound in the diagnosis of movement disorders. Neuroimag Clin N Am. 2010 ; 20 (1): 87-101.

  21. Lv Z, Jiang H, Xu H, Song N, Xie J. Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease. J Neural Transm. 2011 ; 118 (1): 361-9.

  22. Snyder AM, Connor JR. Iron, the substantia nigra and related neurological disorders. BBA. 2009 ; 1790 (7): 606-14.

  23. Van de Loo S, Walter U, Behnke S, Hagenah J, Lorenz M, Sitzer M, et al. Reproducibility and diagnostic accuracy of substantia nigra sonography for the diagnosis of Parkinson´s disease. J Neurol Neurosurg Psychiatry. 2010 ; 81 (10): 1-10.

  24. Berg D, Merz B, Reiners K, Naumann M, Becker G. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson’s disease. Mov Disord. 2005 ; 20 (3): 383-5.

  25. Spiegel J, Hellwig D, Möllers MO, Behnke S, Jost W, Fassbender K, et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson’s disease. Brain. 2006 ; 129 (5): 1188-93.

  26. Walter U, Dressler D, Wolters A, Wittstock M, Benecke R. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson’s disease. Mov Disord. 2007 ; 22 (1): 48-54.




2020     |     www.medigraphic.com